Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2006-05-09
2006-05-09
Kemmerer, Elizabeth C. (Department: 1647)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C424S093700, C514S001000, C514S002600
Reexamination Certificate
active
07041283
ABSTRACT:
A method of treatment of neurodegenerative diseases using neuronal cell transplants is provided. The growth, survival and integration of the transplanted neuronal cells is enhanced by a method of culturing the neuronal cells with drugs having an affinity for immunophilins. Immunophilin binding drugs are optionally administered to the patient during transplantation and/or post-operatively. Neurotrophic factors can also be administered to the neuronal cells in vitro, or to the patient during the transplantation procedure and/or post-operatively.
REFERENCES:
patent: 5696135 (1997-12-01), Steiner et al.
patent: 5968957 (1999-10-01), Hamilton et al.
patent: 6080753 (2000-06-01), Lyons et al.
patent: 6121273 (2000-09-01), Hamilton et al.
patent: 6140116 (2000-10-01), Dinsmore
patent: 6258353 (2001-07-01), Isacson et al.
patent: 2002/0110546 (2002-08-01), Major et al.
ADIS R&D Profile (Jan. 1999) “Sirolimus AY 22989, NSC 226080, NSC 606698, Rapamycin, RAPAMUNE” Drugs R&D 1(1100-107.
Stedman's Medical Dictionary 27th Edition (2000) Lippincott Williams & Wilkins.
Sigma Aldrich Product Information Cyclosporin A (Product No. C 1832)printed from www.sigma.com on Mar. 23, 2004.
Sigma Aldrich Product Information Rapamycin (Product No. R 0395) printed from www.sigma.com on Mar. 24, 2004.
Hale et al. (Feb. 15, 1997) “Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.” Transplantation 63(3): 359-64.
Fricker-Gates et al. (2001) “Neural Transplantation: Restoring Complex Circuitry in the Striatum.” Restorative Neurology and Neuroscience 19(2-3): 119-138.
Savitz et al. (Jan.-Mar. 2003) “Cell Transplants Offer Promise for Stroke Recovery.” The Journal of cardiovascular Nursing 18(1): 57-61.
Wright et al. (Sep. 1999) “A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.” Transplant Immunology 7(3): 141-147.
White et al. (Jan.-Feb. 1999) “Neuron-Enriched Second Trimester Human Cultures: Growth Factor Response and In Vivo Graft Survival.” Cell Transplantation 8(1): 59-73.
Ueda, et al.,Regulation of Endogenous Phosphorylation of Specific Proteins in Synaptic Membrane Fractions from Rat Brain by Adenosine 3′:5′-Monophosphate*, The Journal of Biological Chimistry, (Apr. 2, 1973), pp. 8295-8305, 1073, vol. 248, No. 23, Issue of Dec. 10, USA.
Pamnani, et al.Altered activity of the sodium-potassium pump in arteries of rats with steroid hypertension, Chemical Science and Molecular Medicine, (1978), pp. 41s-43s, vol. 55.
Steiner et al.,High brain densities of the immunophilin FKBP colocalized with calcineurin, Nature, (Aug. 13, 1992), pp. 584-587, vol. 358.
Lyons et al.,Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia, Proc. Natl. Acad. Sci., (Apr. 1994), pp. 3191-3195, vol. 91, USA.
Steiner et al.,Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models, Proc. Natl. Acad. Sci., (Mar. 1997), pp. 2019-2024, vol. 94, USA.
Steiner et al.,Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and Cyclosporin A, Nature Medicine, (Apr. 1997), pp. 421-428, vol. 3, No. 4.
Slader, Jr., et al.,Intrastriatal Grafts from Multiple Donors do not Result in a Proportional Increase in Survival of Dopamine Neurons in Nonhuman Primates, Cell Transplantation, (1998), pp. 87-96, vol. 7, No. 2.
Costantini, et al.,A Novel Immunophilin Ligand: Distinct Branching Effects on Dopaminergic Neurons in Culture and Neurotrophic Actions after Oral Administration in an Animal Model of Parkinson's Disease, Neurobiology of Disease, (1998), pp. 97-106, vol. 5, Article No. NB980185.
Sanders, et al.,A murine model of HIV encephalitis: xenotransplantation of HIV-infected human neuroglia into SCID mouse brain, Neuropathology and Applied Neurobiology, (1998), pp. 461-467, vol. 24.
Achim Cristian L.
Avramut Mihaela
Zeevi Adriana
Eckert Seamans Cherin & Mellott , LLC
Kemmerer Elizabeth C.
Nichols Christopher James
Silverman Arnold B.
University of Pittsburgh-Of the Commonwealth System of Higher Ed
LandOfFree
Methods of using immunophilin binding drugs to improve... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of using immunophilin binding drugs to improve..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using immunophilin binding drugs to improve... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3580840